A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 5, 1996, Pages 513-518

  Angerås, Marianne Hall ^a   Darle, Nils ^a   Hamnström, Katarina ^b   Ekelund, Mats ^c   Engström, Lennart ^d   Takala, Jukka ^e   Viste, Asgaut ^f   Holme, Jörgen Bendix ^g  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Department of Surgery ^*  (Sweden)

^d STOCKHOLM SÖDER HOSPITAL   (Sweden)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g Århus Amts Sygehus   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; CILASTATIN PLUS IMIPENEM; METRONIDAZOLE;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HOSPITAL DISCHARGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; TIME;

EID: 0029807081     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609037950     Document Type: Article

References (36)

1. Kirschner M. Die behandlung der akuten eitrigen freien Bauchfellentzundung. Langenbecks Arch Klin Chir 142: 53, 1926.
2. Altemeier WA. Perspectives in surgical infections. Surg Clin North Am. 60: 5-13, 1980.
3. Andrus C, Doering M, Herrmann VM, Kaminski DL. Planned reoperation of generalized intraabdominal infection. Am J Surg 152: 682-686, 1986.
4. Duff JH, Moffat J. Abdominal sepsis managed by leaving abdomen open. Surgery 90: 774-778, 1981.
5. Garcia-Sabrido JL, Tallado JM, Christou NV. Treatment of severe intraabdominal sepsis and/or necrotic foci by an 'open-abdomen' approach. Zipper and zipper-mesh techniques. Arch Surg 123: 152-156, 1988.
6. Steinberg D. On leaving the peritoneal cavity open in acute generalized suppurative peritonitis. Am J Surg; 137: 216-220, 1979.
7. Baird IM. Multicentered study of cefoperazone for treatment of intraabdominal infections and comparison of cefoperazone with cefamandole and clindamycin plus gentamicin for treatment of appendicitis and peritonitis. Rev Infect Dis 5(Suppl): S165-S171, 1983.
8. Eykyn SJ, Phillips I. Metronidazole in surgical infections. J Antimicrob Chemother 4(Suppl C): 75-81, 1978.
9. Smith JA, Skidmore AG, Forward AD et al. Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis. Ann Surg 192: 213-220, 1980.
10. Stone HH, Fabian TC. Clinical comparison of antibiotic combinations in the treatment of peritonitis and related mixed aerobic-anaerobic surgical sepsis. World J Surg 4: 415-421, 1980.
11. Stone HH, Geheber CE, Kolb LD, Dunlop WE. Clinical comparison of cefotaxime versus the combination of gentamicin plus clindamycin in the treatment of peritonitis and similar polymicrobial soft-tissue surgical sepsis. Clin Ther 4(Suppl A): 67-80, 1981.
12. Stone HH, Strom PR, Fabian TC, Dunlop WE. Third-generation cephalosporins for polymicrobial surgical sepsis. Arch Surg 118: 193-204, 1983.
13. Tally FP, McGowan K, Kellum JM, Gorbach SL, O'Donnell TF. A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg 193: 318-323, 1981.
14. Kager L, Brismar B, Malmborg AS, Nord C-E. Imipenem concentrations in colorectal surgery and impact on the colonic microflora. Antimicrob Agents Chemother 33: 204-208, 1989.
15. Jones RN. Review of the in vitro spectrum of activity of imipenem. Am J Med 78(6A): 22-32, 1985.
16. Thornsberry C. Review of in vitro activity of third generation cephalosporins and other newer β-lactam antibiotics against clinically important bacteria. Am J Med 79(2A): 14-20, 1985.
17. Bustamante CI, Drusano GL, Tatem BA, Standiford HC. Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob Agents Chemother 26: 678-682, 1984.
18. Livermore DM. Clinical significance of β-lactamase and stable depression in gram-negative rods. Eur J Clin Microbiol; 6: 439-445, 1987.
19. Tuomanen E, Tomasz A. Induction of autolysis in nongrowing Escherichia coli. J Bacteriol 167: 1077-1080, 1986.
20. Norrby SR. Imipenem/cilastatin: rationale for a fixed combination. Rev Infect Dis 73: S447-S451, 1985.
21. de Groot, Hustinx PA, Lampe AS, Oosterwijk WM. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections. J Antimicrob Chemother 32: 491-500, 1993.
22. Janvier G, Carles J. Efficacite et tolerance de l'imipeneme/ cilastatine dans le traitement adjuvant de la chirurgie des peritonites chez les patients ages de plus de 70 ans. Ann Chir 47: 370-375, 1993.
23. Eklund A-E, Nord CE, Swedish Study Group. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/ cilastatin in the treatment of severe intra-abdominal infections. J Antimicrob Chemother 31(Suppl A): 79-85, 1993.
24. Cooper GS, Shlaes DM, Salata RA. Intraabdominal infections: differences in presentation and outcome between younger patients and elderly. Clin Inf Dis 19: 146-148, 1994.
25. Solomkin JS, Dellinger EP, Christou NV, Mason AD Jr. Design and conduct of antibiotic trials. A report of the Scientific Studies Committee of the Surgical Infection Society. Arch Surg 122: 158-164, 1987.
26. Solomkin JS, Dellinger EP, Christou NV, Busuttil RW. Results of a multicenter trial comparing imipenem/cilastatin to tobramysin/clindamysin for intra-abdominal infections. Ann Surg 212: 581-591, 1990.
27. Nyström P-O, Bax R, Dellinger EB, Dominioni L, Knaus WA, Meakins JL. Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection. World J Surg 14: 148-158, 1990.
28. Bohnen JNA, Mustard RA, Oxholm SE, Schouten D. APACHE II score and abdominal sepsis. A prospective study. Arch Surg 123: 225-229, 1988.
29. Dellinger EP, Wertz MJ, Meakins JL, Solomkin JS, Allo MD, Howard RJ, Simmons RL. Surgical infection stratification system for intra-abdominal infection: Multicenter trial. Arch Surg 120: 21-29, 1985.
30. Skau T, Nyström PO, Carlsson C. Severity of illness in intraabdominal infection: A comparison of two indexes. Arch Surg 120: 152-158, 1985.
31. Bohnen J, Boulanger M, Meakins JL, McLean APH. Prognosis in general peritonitis: Relation to cause and risk factors. Arch Surg 118: 285-290, 1983.
32. Pitcher WD, Musher DM. Critical importance of early diagnosis and treatment of intraabdominal infection. Arch Surg 117: 328-333, 1982.
33. Schein M, Saadia R, Freinkel Z, Decker GAG. Aggressive treatment of severe diffuse peritonitis: a prospective study. Br J Surg 75: 173-176, 1988.
34. Duyzings JW, Wesdorp RIC, Lemmens HAJ, Greep JM. Ergebnisse einer kombinierten Behandlung von Lavage der Bauchhöhle und lokal verabreichten Antibiotica bei 250 Patienten mit Appendicitis acuta perforata. Chirurgica 51: 519-523, 1980.
35. Leiboff AR, Soroff HS. The treatment of generalized peritonitis by closed postoperative peritoneal lavage. A critical review of the literature. Arch Surg 122: 1005-1010, 1987.
36. Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, Miscall BG, Fry DE. Antibiotic treatment for surgical peritonitis. Ann Surg 214: 543-549, 1991.